Ads
related to: poc diagnostic testing- Contact Us
Reach out to us and we will ensure
you get a personalized response
- Vendor Assessments
Vendor assessment compliant
Industry standard methodology
- Pen Test as a Service
On Demand SaaS Based Pen Test
Self Service Portal, Expert Support
- Cloud Platform
Our SaaS Based Platform Covers All
Your Security Testing Needs.
- Contact Us
hellolingo.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Point-of-care testing (POCT), also called near-patient testing or bedside testing, is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
Point-of-care testing is designed to provide diagnostic tests at or near the time and place that the patient is admitted. POCT uses the concentrations of analytes to provide the user with information on the physiological state of the patient. [ 1 ]
However, current testing methods require days to weeks before results are available limiting the clinical applicability of genetic testing in a number of circumstances. Recently, the first point-of-care genetic test in medicine was demonstrated to be effective in identifying CYP2C19 *2 carriers allowing tailoring of anti-platelet regimens to ...
Truenat is a chip-based, point-of-care, rapid molecular test for diagnosis of infectious diseases. The technology is based on the Taqman RTPCR (Real Time Reverse Transcription Polymerase Chain Reaction) chemistry which can be performed on the portable, battery operated Truelab Real Time micro PCR platform.
Some methods of testing involve collecting saliva using an absorbent pad, applying a chemical solution, and monitoring for color change to indicate a positive or negative result. This method is commonly used as a point-of-care (POC) technique to screen for HIV. However, using absorbent pads and chemical solutions could very easily skew the ...
Point-of-Care (POC) testing Research into POC diagnostic tests has resulted in the development of microfluidic biosensors capable of early diagnostic clinical analysis of cancer-associated miRNAs, which produce cost- and time-efficient results with increased sensitivity and specificity over traditional methods. [ 56 ]
Ad
related to: poc diagnostic testing